glycyrrhizic acid has been researched along with Anterior Choroidal Artery Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Dong, H; Gong, G; Hu, L; Wu, W; Xiang, L; Yin, L; Yuan, L | 1 |
1 other study(ies) available for glycyrrhizic acid and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats.
Topics: Animals; Antioxidants; Apoptosis; Brain Ischemia; Cerebral Infarction; Glycyrrhizic Acid; HMGB1 Protein; Infarction, Middle Cerebral Artery; Inflammation; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Neuroprotective Agents; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley; Reperfusion Injury | 2014 |